Hypogonadotrophic Hypogonadism

Home
Keys to Success in Medicine
Cardiovascular System
Respiratory System
Locomotor System
Endocrine and Metabolic System
Kidneys and Urinary System
Gastrointestinal Tract
Central Nervous System
Haematological System
Integumental System
Reproductive and Genital System
Analysing Medical Investigations
Recommended Reading
Forum
Links

amazon astore

ydr

aces for paces

Clinical Skills Blogspot

 

Google
Web ydr.org.uk
acesforpaces.com medicalrevision.org

 

 

Idiopathic Hypogonadotrophic Hypogonadism                    

Title               

Ñ    Idiopathic Hypogonadotrophic Hypogonadism

Definition

Ñ    Rare genetic condition

Ñ    Insufficient release of gonadotrophin releasing hormone

Ñ    When associated with anosmia it is referred to as Kallman’s syndrome

Aetiology

Ñ    Autosomal dominant

Ñ    Autosomal recessive

Ñ    X-linked

Pathogenesis

Ñ    Abnormal gonadotrophin secretion due to lack of gonadotrophin releasing hormone

Ñ    Results in hypogonadism, infertility and absent, incomplete or partial maturation at puberty

Clinical Features

History:

Sex

Ñ    Males: Females = 4:1

CVS

Ñ    Fatigue

Ñ    Dyspnoea

Ñ    Palpitations

Ñ    Syncope

Associated congenital heart disease

RAG

Ñ    Absent or incomplete puberty

Ñ    Subfertility

Males

Ñ    Decreased libido

Ñ    Erectile dysfunction

Females

Ñ    Primary amenorrhoea

Ñ    Dyspaerunia

CNS

Ñ    Epilepsy:

Kallman’s syndrome

Ñ    Decreased aggressive drive in men

Ñ    Decreased muscle strength

Examination

E&M

Ñ    Eunuchoidal proportions

IS

Ñ    Absence of facial and body hair in males

Ñ    Scanty pubic and axillary hair

CVS

Ñ    Associated congenital heart disease:

ASD, VSD, Ebstein anomaly, transposition of the great vessels, right aortic arch, right bundle branch block, Wolf-Parkinson-White syndrome

GIT

Ñ    Cleft lip and palate:

Small proportion of patients

RAG

Ñ    Lack of breast development in females

Ñ    Small testes and penis in males

CNS

Ñ    Anosmia, colour blindness, sensorineural deafness, paraplegia:

Kallman’s syndrome

Ñ    Decreased muscle strength:

Manifestation of hypogonadism

LMS

Ñ    Osteoporosis

Investigations

Fluids

Blood

Biochemistry

Ñ    Decreased testosterone levels:

Males

Ñ    Decreased oestradiol levels:

Females

Ñ    LH and FSH levels:

Low or low normal

Ñ    Gonadotrophin releasing hormone stimulation test:

Inject GnRH and measure levels of LH and FSH at 15, 30, 45 and 60 minutes

Diminished gonadotrophin response

Pulsatile administration of GnRH for a week restores pituitary responsiveness to GnRH

Imaging

MRI

Ñ    Normal hypothalamus and pituitary

Ñ    Abnormal olfactory systems

Skeletal X-rays

Ñ    Delayed bone age

Management

Support

E&M

Drugs

Ñ    Replacement therapy with either male or female sex hormones

Ñ    Gonadotrophin replacement therapy may be used in an attempt to restore fertility

RAG

Biological agents

Ñ    Assisted contraception may be required in males who do not achieve adequate sperm counts with medical therapy

 

 

Back ] Up ] Next ]

 

 

[Up]